BIPOLAR II DISORDER
Clinical trials for BIPOLAR II DISORDER explained in plain language.
Never miss a new study
Get alerted when new BIPOLAR II DISORDER trials appear
Sign up with your email to follow new studies for BIPOLAR II DISORDER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Tailored obesity drugs offer new hope for bipolar patients
Disease control Recruiting nowThis study aims to find the best weight-loss medication for people with bipolar disorder by matching drugs to specific obesity types (like 'hungry brain' or 'hungry gut'). About 100 adults aged 18-65 with bipolar or schizoaffective disorder and obesity will receive one of three F…
Matched conditions: BIPOLAR II DISORDER
Phase: PHASE4 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated May 26, 2026 03:55 UTC
-
Head-to-Head: lithium vs lamotrigine for bipolar II mood control
Disease control Recruiting nowThis study compares lithium and lamotrigine to see which better stabilizes mood in people with bipolar II disorder. Two hundred adults aged 18-70 will be randomly assigned to one of the two drugs and track their daily mood using a phone app for six months. The goal is to find whi…
Matched conditions: BIPOLAR II DISORDER
Phase: PHASE4 • Sponsor: University Hospital Bispebjerg and Frederiksberg • Aim: Disease control
Last updated May 18, 2026 12:07 UTC
-
New pill could lift bipolar depression without lifelong drugs?
Symptom relief Recruiting nowThis study tests a new medication called azetukalner for people with bipolar I or II disorder who are currently in a depressive episode. Researchers want to see if it reduces depression symptoms better than a placebo over 6 weeks. The trial involves 400 adults aged 18 to 74 and i…
Matched conditions: BIPOLAR II DISORDER
Phase: PHASE3 • Sponsor: Xenon Pharmaceuticals Inc. • Aim: Symptom relief
Last updated May 26, 2026 03:57 UTC
-
New pill hopes to lift bipolar depression in just 6 weeks
Symptom relief Recruiting nowThis study tests a new drug called icalcaprant for adults with bipolar I or II disorder who are currently depressed. About 195 participants will take either the drug or a placebo daily for 6 weeks. Researchers will measure changes in depression symptoms and check for side effects…
Matched conditions: BIPOLAR II DISORDER
Phase: PHASE2 • Sponsor: AbbVie • Aim: Symptom relief
Last updated May 26, 2026 03:53 UTC
-
Time-Restricted eating: a new hope for bipolar mood stability?
Symptom relief Recruiting nowThis study tests whether limiting eating to a 10-hour window each day is a safe and practical addition to standard treatment for bipolar disorder. Forty adults with bipolar I or II who are currently experiencing depression will either receive nutritional counseling alone or combi…
Matched conditions: BIPOLAR II DISORDER
Phase: NA • Sponsor: University of Ottawa • Aim: Symptom relief
Last updated May 20, 2026 11:57 UTC
-
New study aims to unlock secrets of bipolar disorder in teens
Knowledge-focused Recruiting nowThis study follows 80 youth aged 9-19 with bipolar disorder to learn what affects their mood over time. Researchers will track symptoms, inflammation, and family relationships. The goal is to improve diagnosis and treatment for young people with this condition.
Matched conditions: BIPOLAR II DISORDER
Sponsor: University of California, Los Angeles • Aim: Knowledge-focused
Last updated May 22, 2026 13:52 UTC
-
Memory aid could unlock hidden mental health history
Knowledge-focused Recruiting nowThis study tests whether using a life history calendar—a simple grid that helps people recall important life events—can improve how accurately adults in Hong Kong remember and report past mental health problems. Researchers will compare the standard interview method with the cale…
Matched conditions: BIPOLAR II DISORDER
Sponsor: The University of Hong Kong • Aim: Knowledge-focused
Last updated May 12, 2026 13:41 UTC